ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Measles and Rubella Vaccines Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-19R15358
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Measles and Rubella Vaccines Market Insights Forecast to 2029
BUY CHAPTERS

Global Measles and Rubella Vaccines Market Research Report 2025

Code: QYRE-Auto-19R15358
Report
March 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Serum Institute of India Ltd
Takeda Pharmaceutical Company
Merck& Co. Inc

Measles and Rubella Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Measles and Rubella Vaccines Market

Measles and Rubella Vaccines Market

The global market for Measles and Rubella Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Measles and Rubella Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles and Rubella Vaccines.
The Measles and Rubella Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Measles and Rubella Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measles and Rubella Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Measles and Rubella Vaccines Market Report

Report Metric Details
Report Name Measles and Rubella Vaccines Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Serum Institute of India Ltd., Merck & Co. Inc., GlaxoSmithKline Inc., Takeda Pharmaceutical Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Measles and Rubella Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Measles and Rubella Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Measles and Rubella Vaccines Market report?

Ans: The main players in the Measles and Rubella Vaccines Market are Serum Institute of India Ltd., Merck & Co. Inc., GlaxoSmithKline Inc., Takeda Pharmaceutical Company

What are the Application segmentation covered in the Measles and Rubella Vaccines Market report?

Ans: The Applications covered in the Measles and Rubella Vaccines Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Measles and Rubella Vaccines Market report?

Ans: The Types covered in the Measles and Rubella Vaccines Market report are Monovalent Vaccines, Multivalent Vaccines

Recommended Reports

Human Vaccines

Vaccine Technologies

Vaccine Market Operations

1 Measles and Rubella Vaccines Market Overview
1.1 Product Definition
1.2 Measles and Rubella Vaccines by Type
1.2.1 Global Measles and Rubella Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monovalent Vaccines
1.2.3 Multivalent Vaccines
1.3 Measles and Rubella Vaccines by Application
1.3.1 Global Measles and Rubella Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Measles and Rubella Vaccines Market Size Estimates and Forecasts
1.4.1 Global Measles and Rubella Vaccines Revenue 2020-2031
1.4.2 Global Measles and Rubella Vaccines Sales 2020-2031
1.4.3 Global Measles and Rubella Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Measles and Rubella Vaccines Market Competition by Manufacturers
2.1 Global Measles and Rubella Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Measles and Rubella Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Measles and Rubella Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Measles and Rubella Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Measles and Rubella Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles and Rubella Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Measles and Rubella Vaccines, Date of Enter into This Industry
2.8 Global Measles and Rubella Vaccines Market Competitive Situation and Trends
2.8.1 Global Measles and Rubella Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Measles and Rubella Vaccines Players Market Share by Revenue
2.8.3 Global Measles and Rubella Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Measles and Rubella Vaccines Market Scenario by Region
3.1 Global Measles and Rubella Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Measles and Rubella Vaccines Sales by Region: 2020-2031
3.2.1 Global Measles and Rubella Vaccines Sales by Region: 2020-2025
3.2.2 Global Measles and Rubella Vaccines Sales by Region: 2026-2031
3.3 Global Measles and Rubella Vaccines Revenue by Region: 2020-2031
3.3.1 Global Measles and Rubella Vaccines Revenue by Region: 2020-2025
3.3.2 Global Measles and Rubella Vaccines Revenue by Region: 2026-2031
3.4 North America Measles and Rubella Vaccines Market Facts & Figures by Country
3.4.1 North America Measles and Rubella Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Measles and Rubella Vaccines Sales by Country (2020-2031)
3.4.3 North America Measles and Rubella Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Measles and Rubella Vaccines Market Facts & Figures by Country
3.5.1 Europe Measles and Rubella Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Measles and Rubella Vaccines Sales by Country (2020-2031)
3.5.3 Europe Measles and Rubella Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles and Rubella Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Measles and Rubella Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Measles and Rubella Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Measles and Rubella Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Measles and Rubella Vaccines Market Facts & Figures by Country
3.7.1 Latin America Measles and Rubella Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Measles and Rubella Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Measles and Rubella Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles and Rubella Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles and Rubella Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Measles and Rubella Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Measles and Rubella Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles and Rubella Vaccines Sales by Type (2020-2031)
4.1.1 Global Measles and Rubella Vaccines Sales by Type (2020-2025)
4.1.2 Global Measles and Rubella Vaccines Sales by Type (2026-2031)
4.1.3 Global Measles and Rubella Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Measles and Rubella Vaccines Revenue by Type (2020-2031)
4.2.1 Global Measles and Rubella Vaccines Revenue by Type (2020-2025)
4.2.2 Global Measles and Rubella Vaccines Revenue by Type (2026-2031)
4.2.3 Global Measles and Rubella Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Measles and Rubella Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Measles and Rubella Vaccines Sales by Application (2020-2031)
5.1.1 Global Measles and Rubella Vaccines Sales by Application (2020-2025)
5.1.2 Global Measles and Rubella Vaccines Sales by Application (2026-2031)
5.1.3 Global Measles and Rubella Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Measles and Rubella Vaccines Revenue by Application (2020-2031)
5.2.1 Global Measles and Rubella Vaccines Revenue by Application (2020-2025)
5.2.2 Global Measles and Rubella Vaccines Revenue by Application (2026-2031)
5.2.3 Global Measles and Rubella Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Measles and Rubella Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Serum Institute of India Ltd.
6.1.1 Serum Institute of India Ltd. Company Information
6.1.2 Serum Institute of India Ltd. Description and Business Overview
6.1.3 Serum Institute of India Ltd. Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Serum Institute of India Ltd. Measles and Rubella Vaccines Product Portfolio
6.1.5 Serum Institute of India Ltd. Recent Developments/Updates
6.2 Merck & Co. Inc.
6.2.1 Merck & Co. Inc. Company Information
6.2.2 Merck & Co. Inc. Description and Business Overview
6.2.3 Merck & Co. Inc. Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck & Co. Inc. Measles and Rubella Vaccines Product Portfolio
6.2.5 Merck & Co. Inc. Recent Developments/Updates
6.3 GlaxoSmithKline Inc.
6.3.1 GlaxoSmithKline Inc. Company Information
6.3.2 GlaxoSmithKline Inc. Description and Business Overview
6.3.3 GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Portfolio
6.3.5 GlaxoSmithKline Inc. Recent Developments/Updates
6.4 Takeda Pharmaceutical Company
6.4.1 Takeda Pharmaceutical Company Company Information
6.4.2 Takeda Pharmaceutical Company Description and Business Overview
6.4.3 Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Portfolio
6.4.5 Takeda Pharmaceutical Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles and Rubella Vaccines Industry Chain Analysis
7.2 Measles and Rubella Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles and Rubella Vaccines Production Mode & Process Analysis
7.4 Measles and Rubella Vaccines Sales and Marketing
7.4.1 Measles and Rubella Vaccines Sales Channels
7.4.2 Measles and Rubella Vaccines Distributors
7.5 Measles and Rubella Vaccines Customer Analysis
8 Measles and Rubella Vaccines Market Dynamics
8.1 Measles and Rubella Vaccines Industry Trends
8.2 Measles and Rubella Vaccines Market Drivers
8.3 Measles and Rubella Vaccines Market Challenges
8.4 Measles and Rubella Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Serum Institute of India Ltd
Takeda Pharmaceutical Company
Merck& Co. Inc
List of Tables
 Table 1. Global Measles and Rubella Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Measles and Rubella Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Measles and Rubella Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Measles and Rubella Vaccines Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Measles and Rubella Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Measles and Rubella Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Measles and Rubella Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Measles and Rubella Vaccines Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Measles and Rubella Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Measles and Rubella Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Measles and Rubella Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Measles and Rubella Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Measles and Rubella Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles and Rubella Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Measles and Rubella Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Measles and Rubella Vaccines Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Measles and Rubella Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Measles and Rubella Vaccines Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Measles and Rubella Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Measles and Rubella Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Measles and Rubella Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Measles and Rubella Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Measles and Rubella Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Measles and Rubella Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Measles and Rubella Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Measles and Rubella Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Measles and Rubella Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Measles and Rubella Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Measles and Rubella Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Measles and Rubella Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Measles and Rubella Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Measles and Rubella Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Measles and Rubella Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Measles and Rubella Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Measles and Rubella Vaccines Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Measles and Rubella Vaccines Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Measles and Rubella Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Measles and Rubella Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Measles and Rubella Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Measles and Rubella Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Measles and Rubella Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Measles and Rubella Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Measles and Rubella Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Measles and Rubella Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Measles and Rubella Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Measles and Rubella Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Measles and Rubella Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Measles and Rubella Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Measles and Rubella Vaccines Sales (K Doses) by Type (2020-2025)
 Table 51. Global Measles and Rubella Vaccines Sales (K Doses) by Type (2026-2031)
 Table 52. Global Measles and Rubella Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Measles and Rubella Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Measles and Rubella Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Measles and Rubella Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Measles and Rubella Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Measles and Rubella Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Measles and Rubella Vaccines Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Measles and Rubella Vaccines Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Measles and Rubella Vaccines Sales (K Doses) by Application (2020-2025)
 Table 61. Global Measles and Rubella Vaccines Sales (K Doses) by Application (2026-2031)
 Table 62. Global Measles and Rubella Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Measles and Rubella Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Measles and Rubella Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Measles and Rubella Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Measles and Rubella Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Measles and Rubella Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Measles and Rubella Vaccines Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Measles and Rubella Vaccines Price (US$/Dose) by Application (2026-2031)
 Table 70. Serum Institute of India Ltd. Company Information
 Table 71. Serum Institute of India Ltd. Description and Business Overview
 Table 72. Serum Institute of India Ltd. Measles and Rubella Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Serum Institute of India Ltd. Measles and Rubella Vaccines Product
 Table 74. Serum Institute of India Ltd. Recent Developments/Updates
 Table 75. Merck & Co. Inc. Company Information
 Table 76. Merck & Co. Inc. Description and Business Overview
 Table 77. Merck & Co. Inc. Measles and Rubella Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. Merck & Co. Inc. Measles and Rubella Vaccines Product
 Table 79. Merck & Co. Inc. Recent Developments/Updates
 Table 80. GlaxoSmithKline Inc. Company Information
 Table 81. GlaxoSmithKline Inc. Description and Business Overview
 Table 82. GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline Inc. Measles and Rubella Vaccines Product
 Table 84. GlaxoSmithKline Inc. Recent Developments/Updates
 Table 85. Takeda Pharmaceutical Company Company Information
 Table 86. Takeda Pharmaceutical Company Description and Business Overview
 Table 87. Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Takeda Pharmaceutical Company Measles and Rubella Vaccines Product
 Table 89. Takeda Pharmaceutical Company Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Measles and Rubella Vaccines Distributors List
 Table 93. Measles and Rubella Vaccines Customers List
 Table 94. Measles and Rubella Vaccines Market Trends
 Table 95. Measles and Rubella Vaccines Market Drivers
 Table 96. Measles and Rubella Vaccines Market Challenges
 Table 97. Measles and Rubella Vaccines Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Measles and Rubella Vaccines
 Figure 2. Global Measles and Rubella Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Measles and Rubella Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Monovalent Vaccines Product Picture
 Figure 5. Multivalent Vaccines Product Picture
 Figure 6. Global Measles and Rubella Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Measles and Rubella Vaccines Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Measles and Rubella Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Measles and Rubella Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Measles and Rubella Vaccines Sales (2020-2031) & (K Doses)
 Figure 14. Global Measles and Rubella Vaccines Average Price (US$/Dose) & (2020-2031)
 Figure 15. Measles and Rubella Vaccines Report Years Considered
 Figure 16. Measles and Rubella Vaccines Sales Share by Manufacturers in 2024
 Figure 17. Global Measles and Rubella Vaccines Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Measles and Rubella Vaccines Players: Market Share by Revenue in Measles and Rubella Vaccines in 2024
 Figure 19. Measles and Rubella Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Measles and Rubella Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Measles and Rubella Vaccines Sales Market Share by Country (2020-2031)
 Figure 22. North America Measles and Rubella Vaccines Revenue Market Share by Country (2020-2031)
 Figure 23. United States Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Measles and Rubella Vaccines Sales Market Share by Country (2020-2031)
 Figure 26. Europe Measles and Rubella Vaccines Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Measles and Rubella Vaccines Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Measles and Rubella Vaccines Revenue Market Share by Region (2020-2031)
 Figure 34. China Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Measles and Rubella Vaccines Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Measles and Rubella Vaccines Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Measles and Rubella Vaccines Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Measles and Rubella Vaccines Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Measles and Rubella Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Measles and Rubella Vaccines by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Measles and Rubella Vaccines by Type (2020-2031)
 Figure 55. Global Measles and Rubella Vaccines Price (US$/Dose) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Measles and Rubella Vaccines by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Measles and Rubella Vaccines by Application (2020-2031)
 Figure 58. Global Measles and Rubella Vaccines Price (US$/Dose) by Application (2020-2031)
 Figure 59. Measles and Rubella Vaccines Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Measles and Rubella MR Vaccine Market Research Report 2025
Measles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Measles Vaccine Market Research Report 2025
Global Measles Combined with Live Attenuated Vaccine Market Research Report 2025
Global Viral Vaccines Market Research Report 2025
Global Measles and Rubella Vaccine Market Research Report 2025
Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Attenuated Vaccine Market Research Report 2025
Paediatric Vaccine Market
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Influenza Drugs and Vaccines Market Research Report 2025
Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Digital Data Logger Market Insights Forecast to 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GP Vaccination Market Research Report 2025
Global Vaccine Cooler Market Research Report 2025
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Zika Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Shingles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions